Carrageenan-Based Gel Retains Limited Anti-HIV-1 Activity 8–24 Hours After Vaginal Application by HIV-Infected Thai Women Enrolled in a Phase I Safety Trial

Saved in:

Bibliographic Details
Published in:	Journal of acquired immune deficiency syndromes (1999) Vol. 61; no. 5; pp. e71 - e73
Main Authors:	Haaland, Richard E, Chaowanachan, Thanyanan, Evans-Strickfaden, Tammy, van de Wijgert, Janneke H, Kilmarx, Peter H, McLean, Catherine A, Hart, Clyde E
Format:	Journal Article
Language:	English
Published:	United States Lippincott Williams & Wilkins, Inc 15-12-2012
Subjects:	Administration, Intravaginal AIDS/HIV Anti-HIV Agents - administration & dosage Carrageenan - administration & dosage Cross-Over Studies Female Gels HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects HIV-1 - isolation & purification Humans Thailand Therapeutic Irrigation Time Factors Vagina - drug effects Vagina - virology Viral Load - drug effects Thailand
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Feature-2 ObjectType-Correspondence-1 content type line 66 ObjectType-News-4 ObjectType-Article-3
ISSN:	1525-4135 1944-7884
DOI:	10.1097/QAI.0b013e318271c8f9